Jörn Kamradt

1.3k total citations
34 papers, 891 citations indexed

About

Jörn Kamradt is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jörn Kamradt has authored 34 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Surgery. Recurrent topics in Jörn Kamradt's work include Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Treatment and Research (10 papers) and Urinary and Genital Oncology Studies (8 papers). Jörn Kamradt is often cited by papers focused on Bladder and Urothelial Cancer Treatments (10 papers), Prostate Cancer Treatment and Research (10 papers) and Urinary and Genital Oncology Studies (8 papers). Jörn Kamradt collaborates with scholars based in Germany, United States and Switzerland. Jörn Kamradt's co-authors include Michael Stöckle, Jan Lehmann, Bernd Wullich, H. Suttmann, Gerhard Unteregger, Ulrike Zwergel, Stefan Siemer, Jörg Reichrath, Matthias Saar and Wolfgang Tilgen and has published in prestigious journals such as The Journal of Urology, American Journal Of Pathology and International Journal of Cancer.

In The Last Decade

Jörn Kamradt

33 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörn Kamradt Germany 15 373 266 209 141 121 34 891
Salomé González‐Reyes Spain 17 252 0.7× 170 0.6× 157 0.8× 322 2.3× 334 2.8× 34 974
Robert G. Sellers United States 13 517 1.4× 76 0.3× 197 0.9× 102 0.7× 90 0.7× 19 911
Arnold I. Chin United States 14 389 1.0× 168 0.6× 236 1.1× 192 1.4× 233 1.9× 33 992
Gernot Kaber United States 17 309 0.8× 105 0.4× 98 0.5× 72 0.5× 74 0.6× 36 775
Tara A. Sheldrake United Kingdom 13 376 1.0× 106 0.4× 121 0.6× 143 1.0× 59 0.5× 18 1.0k
Isabelle Masouyé Switzerland 19 320 0.9× 75 0.3× 42 0.2× 118 0.8× 101 0.8× 56 1.1k
Katsumi Tsukazaki Japan 18 452 1.2× 161 0.6× 47 0.2× 245 1.7× 128 1.1× 65 1.1k
William E. Munger United States 14 485 1.3× 57 0.2× 141 0.7× 218 1.5× 60 0.5× 20 1.0k
Lihui Wei China 17 262 0.7× 133 0.5× 42 0.2× 128 0.9× 103 0.9× 83 857
Tamara I. Pestina United States 20 460 1.2× 109 0.4× 81 0.4× 155 1.1× 62 0.5× 32 1.1k

Countries citing papers authored by Jörn Kamradt

Since Specialization
Citations

This map shows the geographic impact of Jörn Kamradt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörn Kamradt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörn Kamradt more than expected).

Fields of papers citing papers by Jörn Kamradt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörn Kamradt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörn Kamradt. The network helps show where Jörn Kamradt may publish in the future.

Co-authorship network of co-authors of Jörn Kamradt

This figure shows the co-authorship network connecting the top 25 collaborators of Jörn Kamradt. A scholar is included among the top collaborators of Jörn Kamradt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörn Kamradt. Jörn Kamradt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vitale, Giovanni, Michele Caraglia, Volker Jung, et al.. (2022). Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer. Cancers. 14(12). 2943–2943. 8 indexed citations
2.
Körbel, Christina, Volker Jung, Jörn Kamradt, et al.. (2014). High-Resolution Ultrasound Allows Percutaneous Initiation and Surveillance of Prostate Cancer in an Orthotopic Murine Model. Urologia Internationalis. 94(3). 347–353. 2 indexed citations
3.
Wiechno, Paweł, Bradley G. Somer, Begoña Mellado, et al.. (2013). A Randomised Phase 2 Study Combining LY2181308 Sodium (Survivin Antisense Oligonucleotide) with First-line Docetaxel/Prednisone in Patients with Castration-resistant Prostate Cancer. European Urology. 65(3). 516–520. 50 indexed citations
4.
Saar, Matthias, et al.. (2012). Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes. International braz j urol. 38(3). 324–329. 14 indexed citations
5.
Kamradt, Jörn, Carsten‐Henning Ohlmann, & Michael Stöckle. (2011). Aktuelle Entwicklungen in der Diagnostik und Therapie des Harnblasenkarzinoms. Der Urologe. 50(S1). 179–183.
6.
Saar, Matthias, et al.. (2011). Robotic-assisted laparoscopic radical cystectomy: Evaluation of functional and oncological results. Actas Urológicas Españolas (English Edition). 35(3). 152–157. 3 indexed citations
7.
Saar, Matthias, Christina Körbel, Volker Jung, et al.. (2010). Experimental orthotopic prostate tumor in nude mice: Techniques for local cell inoculation and three-dimensional ultrasound monitoring. Urologic Oncology Seminars and Original Investigations. 30(3). 330–338. 11 indexed citations
8.
Greiner, Markus, Volker Jung, Rainer Grobholz, et al.. (2010). Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells. International Journal of Cancer. 128(10). 2284–2295. 55 indexed citations
9.
Becker, Frank, Stefan Siemer, Jörn Kamradt, Ulrike Zwergel, & Michael Stöckle. (2009). Important Aspects of Organ-Preserving Surgery for Renal Tumors. Deutsches Ärzteblatt international. 106(8). 117–22. 1 indexed citations
10.
Payne, Shannon R., Jürgen Serth, Martin Schostak, et al.. (2009). DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detection. The Prostate. 69(12). 1257–1269. 83 indexed citations
11.
Suttmann, H., Aleksandar Grgic, Jan Lehmann, et al.. (2008). Combining 153 Sm-Lexidronam and Docetaxel for the Treatment of Patients with Hormone-Refractory Prostate Cancer: First Experience. Cancer Biotherapy and Radiopharmaceuticals. 23(5). 609–618. 15 indexed citations
12.
Suttmann, H., Margitta Retz, Friedrich Paulsen, et al.. (2008). Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells. BMC Urology. 8(1). 5–5. 146 indexed citations
13.
Suttmann, H., Jörn Kamradt, Jan Lehmann, & Michael Stöckle. (2007). Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection. British Journal of Urology. 100(6). 1221–1224. 16 indexed citations
14.
Suttmann, H., Jörn Kamradt, Jan Lehmann, & Michael Stöckle. (2007). Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy. British Journal of Urology. 100(6). 1225–1228. 6 indexed citations
15.
Lehmann, Jan, H. Suttmann, Markus Hack, et al.. (2006). Transitional Cell Carcinoma of the Ureter: Prognostic Factors Influencing Progression and Survival. European Urology. 51(5). 1281–1288. 67 indexed citations
16.
Florl, Andrea R., Jörn Kamradt, Jan Lehmann, et al.. (2005). Relationship of NKX3.1 and MYC Gene Copy Number Ratio and DNA Hypomethylation to Prostate Carcinoma Stage. European Urology. 49(1). 169–175. 13 indexed citations
17.
Diesel, Britta, Michael Friedrich, Viktor Meineke, et al.. (2004). Analysis of the vitamin D system in basal cell carcinomas (BCCs). Laboratory Investigation. 84(6). 693–702. 64 indexed citations
18.
Kamradt, Jörn, Viktor Meineke, Barbara C. Gärtner, et al.. (2003). Analysis of the Vitamin D system in Cutaneous Malignancies. Recent results in cancer research. 164. 259–269. 29 indexed citations
19.
Götz, Claudia, Axel Bex, Jan Lehmann, et al.. (2002). Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice. International Journal of Oncology. 21(4). 695–706. 13 indexed citations
20.
Kamradt, Jörn & Jörg Reichrath. (1996). Expression of retinoic acid receptor proteins in basal cell carcinomas: an immunohistochemical analysis.. Journal of Histochemistry & Cytochemistry. 44(12). 1415–1420. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salomé González‐Reyes Breakdown of academic impact, for papers by Robert G. Sellers Breakdown of academic impact, for papers by Arnold I. Chin Breakdown of academic impact, for papers by Gernot Kaber Breakdown of academic impact, for papers by Tara A. Sheldrake Breakdown of academic impact, for papers by Isabelle Masouyé Breakdown of academic impact, for papers by Katsumi Tsukazaki Breakdown of academic impact, for papers by William E. Munger Breakdown of academic impact, for papers by Lihui Wei Breakdown of academic impact, for papers by Tamara I. Pestina
Rankless by CCL
2026